Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer

W. J. Gradishar, S. B. Wedam, M. Jahanzeb, J. Erban, S. A. Limentani, K. T. Tsai, S. R. Olsen, S. M. Swain*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences